Apolipoprotein CIII

<strong>Apolipoprotein CIII</strong>_x000D_ <strong>Catalog number:</strong> B2014955_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 8750_x000D_ <strong>Supplied as:</strong> Frozen_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> Apolipoprotein CIII, Human Plasma_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tramontano D, Bini S, D'Erasmo L, Arca M. Recent Apolipoprotein CIII trials Curr Opin Lipidol. 2022 Dec 1;33(6):309-318._x000D_ 2: Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, O'Dea L, Bruckert E. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome N Engl J Med. 2019 Aug 8;381(6):531-542._x000D_ 3: Sandin Å, Olofsson C, Strålfors A, Rajamand Ekberg N, Brismar K, Juntti-Berggren L, Eggertsen G. Human apolipoprotein CIII levels; evaluation of three assay methods Scand J Clin Lab Invest. 2020 May;80(3):230-235._x000D_ 4: Naber A, Demus D, Slieker R, Nicolardi S, Beulens JWJ, Elders PJM, Lieverse AG, Sijbrands EJG, 't Hart LM, Wuhrer M, van Hoek M. Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids Int J Mol Sci. 2023 Oct 2;24(19):14844._x000D_ 5: Sinari S, Koska J, Hu Y, Furtado J, Jensen MK, Budoff MJ, Nedelkov D, McClelland RL, Billheimer D, Reaven P. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1560-1571._x000D_ 6: Kawakami A, Yoshida M. Apolipoprotein CIII links dyslipidemia with atherosclerosis J Atheroscler Thromb. 2009 Mar;16(1):6-11._x000D_ 7: Harney DJ, Hutchison AT, Hatchwell L, Humphrey SJ, James DE, Hocking S, Heilbronn LK, Larance M. Proteomic Analysis of Human Plasma during Intermittent Fasting J Proteome Res. 2019 May 3;18(5):2228-2240._x000D_ 8: Yan H, Niimi M, Matsuhisa F, Zhou H, Kitajima S, Chen Y, Wang C, Yang X, Yao J, Yang D, Zhang J, Murakami M, Nakajima K, Wang Y, Liu E, Liang J, Chen YE, Fan J. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2095-2107._x000D_ 9: Prakash TP, Graham MJ, Yu J, Carty R, Low A, Chappell A, Schmidt K, Zhao C, Aghajan M, Murray HF, Riney S, Booten SL, Murray SF, Gaus H, Crosby J, Lima WF, Guo S, Monia BP, Swayze EE, Seth PP. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice Nucleic Acids Res. 2014 Jul;42(13):8796-807._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/32805056">10: Fernandez ML. The Positive Association of Plasma Myristic Acid and Apolipoprotein CIII Concentrations J Nutr. 2020 Oct 12;150(10):2613-2614. </a>_x000D_ _x000D_ <strong>Products Related to Apolipoprotein CIII can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>